Table 2

Characteristics of 31 patients on negative pressure ventilation (shell or tank)

Diagnosis Poliomyelitis Non-Duchenne's myopathies Motor neurone
disease
Diaphragmatic paralysis Multiple sclerosis
No. of patients (M/F)25 (13/12)2 (1/1)2 (1/1)1(0/1)1(0/1)
Age when ventilator started (years)26.0 (10.2)18.5 (0.71)62.0 (12.7)2947
Height (cm)169.1 (11.5)156.2 (34.1)161.3 (1.8)160154.9
Weight (kg)57.7 (12.2)33.2 (1.3)44.8 (8.7)56.457.7
FVC (ml; % predicted)
a800 (383); 20 (8)%625 (460); 19 (9)%950 (50); 34 (3)%1300; 44%1300; 63%
 b730 (336); 19 (7)%550 (495); 14 (14)%300 (20); 9 (3)%1200; 38%1270; 57%
Pco 2(mm Hg)
a46.1 (10.0)2-151 51.5 (0.71)50.5 (6.5)6243
 b46.5 (14.5)68.5 (14.8)46.5 (9.2)4834
Time on non-invasive ventilation (months)290 (148)2-164 46 (31)174 (229)46396
Gain or decline in FVC
 ml/year−4.8 (13.8)2-152 −81.3 (97.2)−25.0 (0)−26.1−7.0
 % predicted/year−0.09 (0.31)−2.0 (1.4)−0.8 (0)−1.6−1.4
No. of patients eventually needing trachostomy142-153 2100
No. of deaths62-150 0201
  • Values are mean (SD) unless otherwise stated.

  • a = before ventilation; b = near end of period on ventilation; FVC = forced vital capacity; Pco 2 = carbon dioxide tension.

  • 2-151 Significantly different from polio-M/NIPPV patients (table 3), p<0.05 (Wilcoxon rank sum test).

  • 2-164 Significantly different from polio-M/NIPPV patients (table 3), p< 0.01 (Wilcoxon rank sum test).

  • 2-152 Significantly different from polio-M/NIPPV patients (table 3), p<0.01 (Wilcoxon rank sum test).

  • 2-153 Significantly different from polio-M/NIPPV patients (table 3), p<0.01 (Wilcoxon rank sum test).

  • 2-150 Significantly different from polio-M/NIPPV patients (table 3), p<0.01 (Wilcoxon rank sum test).